A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis

Study Purpose:

A multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of arimoclomol in amyotropic lateral sclerosis (ALS)

Study Status:

Not recruiting

Disease:

Amyotrophic Lateral Sclerosis

Study Type:

Interventional

Type of Intervention:

Drug

Intervention Name:

Arimoclomol, Placebo oral capsule

Placebo:

Yes

Phase:

Phase 3

Study Chair(s)/Principal Investigator(s):

Michael Benatar, MD PhD, University of Miami

Clinicaltrials.gov ID:

NCT03491462

Neals Affiliated?

No

Coordinating Center Contact Information

Full Study Summary:

Screening of up to 4 weeks Treatment of up to 76 weeks

Study Sponsor:

ZevraDenmark

Participant Duration:

Screening of up to 4 weeks Treatment of up to 76 weeks

Estimated Enrollment:

245

Estimated Study Start Date:

07 / 31 / 2018

Estimated Study Completion Date:

12 / 18 / 2020

Posting Last Modified Date:

01 / 20 / 2021

Date Study Added to neals.org:

04 / 09 / 2018

Minimum Age:

18 Years

Maximum Age:

N/A

Can participants use Riluzole?

Yes

Inclusion Criteria:

- Subject meets revised El Escorial criteria for clinically possible, clinically probable / Clinically probable ALS laboratory-supported or clinically definite ALS, or familial ALS

- 18 months or less since first appearance of weakness (e.g. limb weakness, dysarthria, dysphagia, shortness of breath).

- ALSFRS-R equal to or above 35 and erect (seated) SVC% predicted equal to or above 70% at screening

Exclusion Criteria:

- Tracheostomy or use of non-invasive ventilation for more than 2 hours during waking hours at the time of screening or baseline

- pregnant or breast-feeding

- current or anticipated use of diaphragmatic pacing

- Any other relevant medically significant condition which could present risk to the subject or interfere with the assessment of safety or has an increased risk of causing death during the trial

St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center

Phoenix, Arizona 85013
United States

HonorHealth Neurology

Phoenix, Arizona 85018
United States

UC Irvine Health ALS and Neuromuscular Center

Orange, California 92868
United States

University of Miami

Miami, Florida 33136
United States

University of Kansas Medical Center (KUMC) - Landon Center on Aging

Kansas City, Kansas 66160
United States

Hospital for Special Surgery

New York, New York 10021
United States

Providence Brain & Spine Institute

Portland, Oregon 97213
United States

University of Pensylvania, Perelman Center for Advanced Medicine - Penn Neuroscience Center

Philadelphia, Pennsylvania 19107
United States

University of Texas Southwestern Medical Center

Dallas, Texas 75390
United States

University of Virginia Health System

Charlottesville, Virginia 22908
United States

Catholic University Leuven

Leuven 3000
Belgium

London Health Sciences Centre

London, Ontario N6A 5A5
Canada

Sunnybrook Health Sciences Centre

Toronto, Ontario M4N 3M5
Canada

Montreal Neurological Institute and Hospital

Montréal, Quebec H3A 2B4
Canada

Centre Hospitalier Regional Universitaire (CHRU) Montpellier - Hopital Gui De Chauliac

Montpellier 34295
France

Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422

Paris 75013
France

Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) - Ambulanz fuer ALS und andere Motoneuronenerkrankungen

Berlin 13353
Germany

Medizinische Hochschule Hannover (MHH) - Klinik fuer Neurologie

Hannover 30625
Germany

Universitaetsklinikum Ulm - Klinik fuer Neurologie

Ulm 89081
Germany

Instituti Clinica Scientifici Maugeri - IRCCS

Milano 20138
Italy

Azienda Ospedaliero Universitaria (AUO) di Torino - Citta'della Salute e della Scienza di Torino

Torino 10126
Italy

University Medical Center Utrecht

Utrecht 3584CX
Netherlands

Centrum Medyczne NeuroProtect

Warsaw 01-684
Poland

Citi Clinic

Warsaw 02-473
Poland

Hospital Universitario Vall d'Hebron ALS Unit. Consultas Externas; Office: 9-10-11

Barcelona 08035
Spain

Hospital Carlos III - Hospital Universitario La Paz, ALS Unit

Madrid 28046
Spain

Umeå University Hospital

Umeå 90737
Sweden

Kantonsspital St.Gallen, Muskelzentrum/ALS Clinic

Saint Gallen 9007
Switzerland

Leonard Wolfson Experimental Neurology Centre

London WC1N 3BG
United Kingdom